Pesquisar

A presente ficha temática explica as normas da UE sobre medicamentos e dispositivos médicos, assim como o sólido quadro jurídico em vigor para proteger a saúde pública e garantir a segurança destes produtos. Demais, incide sobre aspetos primordiais neste domínio, como sejam o fornecimento de medicamentos, a luta contra a resistência antimicrobiana, a realização ética de ensaios clínicos e desafios como a pandemia de COVID-19 e diversos acontecimentos geopolíticos.

A presente ficha temática descreve os objetivos da política de saúde pública da UE e o contexto em que esta política evolui. Apresenta as principais realizações da UE na promoção da saúde e na prevenção de doenças, com destaque para a luta contra o cancro e o aumento da resiliência contra as doenças infecciosas e as ameaças sanitárias transfronteiras. Debruça-se sobre os desafios de saúde pública associados às alterações demográficas, bem como sobre a necessidade de garantir o acesso aos medicamentos ...

The public policy ideal should be to provide high-quality healthcare to all EU citizens and residents in each Member State, also through cross-border cooperation, that, in turn, incentivises improvements in national healthcare systems. Difficulties in accessing cross-border healthcare become apparent when the coordination of public healthcare systems intersects with the free movement of market (private) healthcare services and goods. Inter alia, this paper presents the current challenges and possible ...

This study examines the health effects of fine particulate matter (PM2.5 and PM10), trends in exposure, and the effectiveness of EU legal and policy frameworks. It draws on an umbrella review of 198 systematic reviews, quantitative analysis of exposure trends, stakeholder interviews, and comparative case studies across EU Member States. The study shows consistent health effects of PM2.5 exposure across multiple disease categories and identifies persistent inequalities in exposure across populations ...

This infographic presents the key facts and policy challenges surrounding childhood cancer, a rare but highly impactful disease that remains the leading disease-related cause of death beyond infancy in Europe. The infographic underlines that children are not small adults, but rather require specific approaches to diagnosis, treatment, research, rehabilitation, and long-term survivorship care. It also highlights the persistent inequalities in access to specialised paediatric oncology services across ...

A presente ficha temática explica a ação da UE para reduzir a poluição atmosférica e a poluição sonora e proteger a saúde humana e o ambiente. Descreve as principais fontes de poluição e os seus impactos, os objetivos de poluição zero da UE e a legislação fundamental que trata das emissões da indústria, dos transportes e de outros setores. Destaca igualmente os progressos realizados e os desafios que subsistem na melhoria da qualidade do ar e na redução do ruído ambiente.

This briefing provides a legal analysis and critical assessment of the genetically modified micro-organisms (GMM) component of the Commission proposal for a Directive amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs. This proposal was presented in December 2025 and accompanies the European Biotech Act. The briefing presents and analyses the proposed GMM-related amendments, situates the proposal ...

New and emerging plant pests can undermine EU food security and farm/forestry incomes through yield losses, trade disruption and costly control measures, while also causing major environmental impacts through biodiversity loss, landscape change and increased pressure to use pesticides. Using a comprehensive foresight methodology, this study examines how global trade and tourism, climate change and agricultural systems contribute to the introduction and spread of new and emerging plant pests, assesses ...

Youth mental ill-health in the EU-27 is high, rising and increasingly associated with digital environments. This study shows how persuasive platform design, harmful content and emerging AI-mediated interactions amplify offline vulnerabilities in the context of under-resourced, fragmented services and a large 'missing middle' between schools and specialist care. Using seven country case studies and an EU-27 cost model, it estimates that youth mental ill-health will cost about €1.68 trillion over 2024 ...

The European Biotech Act I, proposed in December 2025, is the EU’s first standalone legislation regulating health biotechnology across its full lifecycle, from research to market placement. This briefing sets the Act’s scope and rationale against the sector’s economic weight and the widening global competitiveness gap. It maps the scope and regulatory landscape and places it in its competitiveness context. The briefing also profiles leading biotech hubs across Member States and identifies structural ...